The Landscape of Products for Diabetic Peripheral Neuropathy: A Scientific and Patent Systematic Review

被引：0

作者：

dos Santos Barros, Giselda ^{[1
]}

dos Passos Menezes, Paula ^{[1
,2
]}

de Cássia Silva, Simone ^{[3
]}

Francisco da Silva, Gabriel ^{[1
]}

机构：

[1] Postgraduate Program in Intellectual Property Science, Federal University of Sergipe, São Cristóvão, Sergipe

[2] SejaPhD, Sergipe

[3] Department of Production Engineering (DEPRO), Federal University of Sergipe, São Cristóvão, Sergipe

来源：

Recent Patents on Biotechnology | 2025年 / 19卷 / 03期

关键词：

Biomedical technology; diabetic peripheral neuropathy; high-income countries; patent; review studies; SWOT analysis;

D O I：

10.2174/0118722083314714240820115610

中图分类号：

学科分类号：

摘要：

Background: Diabetic peripheral neuropathy (DPN) is a complication of diabetes that occurs in 40 - 60 million individuals worldwide and is associated with other chronic diseases. However, there are no review studies that present the state-of- the- art and technologies developed to circumvent this important health problem. Materials and Methods: This review was conducted based on scientific papers and patents. The papers were retrieved from Lilacs, PubMed, and Web of Science databases, and the patents from INPI, ESPACENET, WIPO, and GOOGLE PATENTS. Thus, a sample consisting of 14 scientific articles and 667 patents was analyzed. Results: From the analysis of the data, we drew an overview of the development of biomedical technologies for DPN and detected the pioneering spirit of China, the USA, and Japan in the area, with a focus on the treatment of DPN. Based on this, we carried out a SWOT analysis to help direct future efforts in the area, which should focus primarily on developing technologies for prevention, early diagnosis, and, above all, cure of the disease to reduce the important impact of this disease in various sectors of society. Conclusion: This study finds a concentration of diabetic peripheral neuropathy products, especially therapeutic drugs, in high-income countries. It highlights the need for global collaboration and strategic focus on therapeutic adherence and preventive strategies to effectively manage DPN. © 2025 Bentham Science Publishers.

引用

页码：221 / 243

页数：22

共 67 条

[1]

Yu Y., Gold Standard for Diagnosis of DPN, Front. Endocrinol, 12, (2021)

[2]

Pop-Busui R., Ang L., Boulton A.J., Et al., Diagnosis and treatment of painful diabetic peripheral neuropathy, pp. 1-32, (2022)

[3]

Chitneni A., Rupp A., Ghorayeb J., Abd-Elsayed A., Early detection of diabetic peripheral neuropathy by fMRI: An evidence-based review, Brain Sci, 12, 5, (2022)

[4]

Rolim L.T.P., Flumignan R., Diagnstico e tratamento da neuropatia perifrica diabtica, (2022)

[5]

Zhu J., Hu Z., Luo Y., Et al., Diabetic peripheral neuropathy: Pathogenetic mechanisms and treatment, Front. Endocrinol. (Lausanne), 14, (2024)

[6]

Chakraborty S., Majumder A., Prevalence and correlates of peripheral neuropathy amongst type 2 diabetes mellitus patients – A community based epidemiological study in a town of eastern India, J Med Evid, 4, 2, pp. 130-135, (2023)

[7]

Gandhi M., Fargo E., Prasad-Reddy L., Mahoney K.M., Isaacs D., Diabetes: How to manage diabetic peripheral neuropathy, Drugs Context, 11, pp. 1-13, (2022)

[8]

Fan R.R., Gibson A.K., Smeds M.R., Zakhary E., Impact of socioeconomic status on major amputation in patients with peripheral vascular disease and diabetes mellitus, Ann. Vasc. Surg, 87, pp. 78-86, (2022)

[9]

Ha J.H., Jin H., Park J.U., Association between socioeconomic position and diabetic foot ulcer outcomes: A population-based cohort study in South Korea, BMC Public Health, 21, 1, (2021)

[10]

Tatulashvili S., Fagherazzi G., Dow C., Cohen R., Fosse S., Bihan H., Socioeconomic inequalities and type 2 diabetes complications: A systematic review, Diabetes Metab, 46, 2, pp. 89-99, (2020)

← 1 2 3 4 5 6 7 →